Clinical trial screening of CDKN2A genomic alterations in patients with pancreatic cancer and hepatobiliary cancers requires greater precision than somatic sequencing alone.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: NantOmics LLC (United States)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2912181628
